Home » AstraZeneca Heart Drug Wins European Green Light
AstraZeneca Heart Drug Wins European Green Light
AstraZeneca’s new heart medicine Brilinta won a green light from regulators in Europe, boosting prospects for the group’s biggest drug hope.
Finanz Nachrichten
Finanz Nachrichten
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May